Precigen Inc (NASDAQ:PGEN) price on Thursday, March 20, rose 0.56% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $1.80.
A look at the stock’s price movement, the close in the last trading session was $1.79, moving within a range at $1.7 and $1.83. Turning to its 52-week performance, $2.17 and $0.65 were the 52-week high and 52-week low respectively. Overall, PGEN moved -11.33% over the past month.
Precigen Inc’s market cap currently stands at around $529.28 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Mar-18.
The average forecast suggests down to a -43.66% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 16.06M, representing a 309.17% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that PGEN is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
2 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 2 recommend PGEN as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
PGEN’s current price about 0.95% and 13.59% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 54.25, while 7-day volatility ratio is 7.73% and 9.76% in the 30-day chart. Further, Precigen Inc (PGEN) has a beta value of 1.62, and an average true range (ATR) of 0.15. Analysts have given the company’s stock an average 52-week price target of $6, forecast between a low of $6 and high of $6. Looking at the price targets, the low is -233.33% off current price level while to achieve the yearly target high, price needs to move -233.33%. Nonetheless, investors will most likely welcome a -233.33% jump to $6 which is the analysts’ median price.
If we refocus on Precigen Inc (NASDAQ:PGEN), historical trading data shows that trading volumes averaged 1.18 over the past 10 days and 2.07 million over the past 3 months. The company’s latest data on shares outstanding shows there are 292.87 million shares.
The 44.43% of Precigen Inc’s shares are in the hands of company insiders while institutional holders own 25.98% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 21.57 million on 2025-02-28, giving us a short ratio of 9.69. The data shows that as of 2025-02-28 short interest in Precigen Inc (PGEN) stood at 1123.99995 of shares outstanding, with shares short rising to 19.04 million registered in 2025-01-31. Current price change has pushed the stock 60.71% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the PGEN stock continues to rise going into the next quarter.
